Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects

References

• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12. doi:10.1007/s11906-018-0812-z.
   Google Scholar
• Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT, et al. Altered Gut microbiota in mice lacking toll-like receptor 5. Science. 2010;328:228–15. doi:10.1126/science.1179721.
   Google Scholar
• Derrien M, Alvarez AS, de Vos WM. The Gut microbiota in the first decade of life. Trends Microbiol. 2019;27:997–1010. doi:10.1016/j.tim.2019.08.001.
   Google Scholar
• Garwood P, Chaib F, Brogan C. Tenfold increase in childhood and adolescent obesity in four decades: new study by Imperial College London and WHO. London (UK): World Health Organization; 2017 Oct 11 [accessed 2021 Jan 1]. https://www.who.int/news/item/11-10-2017-tenfold-increase-in-childhood-and-adolescent-obesity-in-four-decades-new-study-by-imperial-college-london-and-who.
   Google Scholar
• Bjerregaard LG, Jensen BW, Ängquist L, Osler M, TIA S, Baker JL. Change in overweight from childhood to early adulthood and risk of Type 2 diabetes. N Engl J Med. 2018;378:1302–1312. doi:10.1056/NEJMoa1713231.
   Google Scholar
• Weihe P, Weihrauch-Blüher S. Metabolic syndrome in children and adolescents: diagnostic criteria, therapeutic options and perspectives. Curr Obes Rep. 2019;8:472–479. doi:10.1007/s13679-019-00357-x.
   Google Scholar
• Magge SN, Goodman E, Armstrong SC. The metabolic syndrome in children and Adolescents: shifting the focus to cardiometabolic risk factor clustering. Pediatr. 2017:140. doi:10.1542/peds.2017-1603.
   Google Scholar
• Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):101. doi:10.1186/s12889-017-4041-1.
   Google Scholar
• de Groot PF, Frissen MN, de Clercq NC, Nieuwdorp M. Fecal microbiota transplantation in metabolic syndrome: history, present and future. Gut Microbes. 2017;8(3):253–267. doi:10.1080/19490976.2017.1293224.
   Google Scholar
• Sircana A, Framarin L, Leone N, Berrutti M, Castellino F, Parente R, De Michieli F, Paschetta E, Musso G. Altered Gut Microbiota in Type 2 Diabetes: just a Coincidence? Curr Diab Rep. 2018;18:98. doi:10.1007/s11892-018-1057-6.
   Google Scholar
• Deschasaux M, Bouter KE, Prodan A, Levin E, Groen AK, Herrema H, Tremaroli V, Bakker GJ, Attaye I, Pinto-Sietsma SJ, et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med. 2018;24(10):1526–1531. doi:10.1038/s41591-018-0160-1.
   Google Scholar
• Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23(7):850–858. doi:10.1038/nm.4345.
   Google Scholar
• Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359(6380):1151–1156. doi:10.1126/science.aao5774.
   Google Scholar
• Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210–215. doi:10.1038/nature25973.
   Google Scholar
• Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao J, Abe F, Osawa R. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016;16:90. doi:10.1186/s12866-016-0708-5.
   Google Scholar
• Liu Y, Qin S, Song Y, Feng Y, Lv N, Xue Y, Liu F, Wang S, Zhu B, Ma J, et al. The Perturbation of Infant Gut Microbiota Caused by Cesarean Delivery Is Partially Restored by Exclusive Breastfeeding. Front Microbiol. 2019;10:598. doi:10.3389/fmicb.2019.00598.
   Google Scholar
• Payne AN, Chassard C, Zimmermann M, Müller P, Stinca S, Lacroix C. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes. 2011;1:e12. doi:10.1038/nutd.2011.8.
   Google Scholar
• Xu P, Li M, Zhang J, Zhang T. Correlation of intestinal microbiota with overweight and obesity in Kazakh school children. BMC Microbiol. 2012;12(1):283. doi:10.1186/1471-2180-12-283.
   Google Scholar
• Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, Berry D. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations. Environ Microbiol. 2017;19:95–105. doi:10.1111/1462-2920.13463.
   Google Scholar
• Méndez-Salazar EO, Ortiz-López MG, Granados-Silvestre M, Palacios-González B, Menjivar M. Altered Gut Microbiota and Compositional Changes in Firmicutes and Proteobacteria in Mexican Undernourished and Obese Children. Front Microbiol. 2018;9:2494. doi:10.1007/s00394-017-1445-8.
   Google Scholar
• Bai J, Hu Y, Bruner DW. Composition of gut microbiota and its association with body mass index and lifestyle factors in a cohort of 7-18 years old children from the American Gut Project. Pediatr Obes. 2019;14(4):e12480. doi:10.1111/ijpo.12480.
   Google Scholar
• Zhao Y, Zhou J, Liu J, Wang Z, Chen M, Zhou S. Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease. Front Pediatr. 2019;7:518. doi:10.3389/fped.2019.00518.
   Google Scholar
• Gallardo-Becerra L, Cornejo-Granados F, García-López R, Valdez-Lara A, Bikel S, Canizales-Quinteros S, López-Contreras BE, Mendoza-Vargas A, Nielsen H, Ochoa-Leyva A. Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children. Microb Cell Fact. 2020:19,61. doi:10.1186/s12934-020-01319-y.
   Google Scholar
• Quiroga R, Nistal E, Estébanez B, Porras D, Juárez-Fernández M, Martínez-Flórez S, García-Mediavilla MV, de Paz JA, González-Gallego J, Sánchez-Campos S, et al. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Exp Mol Med. 2020;52(7):1048–1061. doi:10.1111/1462-2920.13463.
   Google Scholar
• Chen X, Sun H, Jiang F, Shen Y, Li X, Hu X, Shen X, Wei P. Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing. PeerJ. 2020;8:e8317. doi:10.7717/peerj.8317.
   Google Scholar
• Cho KY. Lifestyle modifications result in alterations in the gut microbiota in obese children. BMC Microbiol. 2021;21(1):10. doi:10.1002/1873-3468.13064.
   Google Scholar
• Zhong H, Penders J, Shi Z, Ren H, Cai K, Fang C, Ding Q, Thijs C, EE B, Stehouwer CDA, et al. Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children. Microbiome. 2019;7:2. doi:10.1186/s40168-018-0608-z.
   Google Scholar
• Hollister EB, Riehle K, Luna RA, Weidler EM, Rubio-Gonzales M, Mistretta TA, Raza S, Doddapaneni HV, Metcalf GA, Muzny DM, et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome. 2015;3:36. doi:10.1186/s40168-015-0101-x.
   Google Scholar
• Nirmalkar K, Murugesan S, Pizano-Zárate ML, Villalobos-Flores LE, García-González C, Morales-Hernández RM, Nuñez-Hernández JA, Hernández-Quiroz F, Romero-Figueroa M, del S, et al. Gut microbiota and endothelial dysfunction markers in obese mexican children and adolescents. Nutrients. 2018; 10: doi:10.3390/nu10122009.
   Google Scholar
• Brüssow H. Problems with the concept of gut microbiota dysbiosis. Microb Biotechnol. 2020;13(2):423–434. doi:10.1111/1751-7915.13479.
   Google Scholar
• Velmurugan G, Dinakaran V, Rajendhran J, Swaminathan K. Blood microbiota and circulating microbial metabolites in diabetes and cardiovascular disease. Trends Endocrinol Metab. 2020;31:835–847. doi:10.1016/j.tem.2020.01.013.
   Google Scholar
• Segal JP, Mullish BH, Quraishi MN, Acharjee A, Williams HRT, Iqbal T, Hart AL, Marchesi JR. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease. Therap Adv Gastroenterol. 2019:12. doi:10.1177/1756284818822250.
   Google Scholar
• Quince C, Walker AW, Simpson JT, Loman NJ, Segata N. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol. 2017;35:833–844. doi:10.1038/nbt.3935.
   Google Scholar
• Wang X, Zhang A, Miao J, Sun H, Yan G, Wu F, Wang X. Gut microbiota as important modulator of metabolism in health and disease. RSC Adv. 2018;8:42380–42389. doi:10.1039/C8RA08094A.
   Google Scholar
• Burgueño JF, Abreu MT. Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol. 2020;17:263–278. doi:10.1038/s41575-019-0261-4.
   Google Scholar
• Pingitore A, Gonzalez-Abuin N, Ruz-Maldonado I, Huang GC, Frost G, Persaud SJ. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: role of free fatty acid receptor 2. Diabetes Obes Metab. 2019;21:330–339. doi:10.1111/dom.13529.
   Google Scholar
• Koh A, Vadder FD, Kovatcheva-Datchary P, From Dietary BF. Fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332–1345. doi:10.1016/j.cell.2016.05.041.
   Google Scholar
• Sivaprakasam S, Bhutia YD, Yang S, Ganapathy V. Short-chain fatty acid transporters: role in colonic homeostasis. Compr Physiol. 2017;8:299–314. doi:10.1002/cphy.c170014.
   Google Scholar
• Li M, van Esch BCAM, Wagenaar GTM, Garssen J, Folkerts G, Henricks PAJ. Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol. 2018;831:52–59. doi:10.1016/j.ejphar.2018.05.003.
   Google Scholar
• Christiansen CB, Gabe MBN, Svendsen B, Dragsted LO, Rosenkilde MM, Holst JJ. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. Am J of Physiol Gastrointest Liver Physiol. 2018;315:G53–G65. doi:10.1152/ajpgi.00346.2017.
   Google Scholar
• Kuhre RE, Christiansen CB, Saltiel MY, Albrechtsen NJW, Holst JJ. On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat. Physiol Rep. 2017;5:e13507. doi:10.14814/phy2.13507.
   Google Scholar
• Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, Pluznick JL. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics. 2016;48:826–834. doi:10.1152/physiolgenomics.00089.2016.
   Google Scholar
• Li X, Watanabe K, Kimura I. Gut microbiota dysbiosis drives and implies novel therapeutic strategies for diabetes mellitus and related metabolic diseases. Front Immunol. 2017;8:1882. doi:10.3389/fimmu.2017.01882.
   Google Scholar
• Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277. doi:10.3389/fimmu.2019.00277.
   Google Scholar
• Peredo-Lovillo A, Romero-Luna HE, Jiménez-Fernández M. Health promoting microbial metabolites produced by gut microbiota after prebiotics metabolism. Food Res Int. 2020;136:109473. doi:10.1016/j.foodres.2020.109473.
   Google Scholar
• Cani PD. Gut cell metabolism shapes the microbiome. Science. 2017;357:548–549. doi:10.1126/science.aao2202.
   Google Scholar
• Byndloss MX, Olsan EE, Rivera-Chávez F, Tiffany CR, Cevallos SA, Lokken KL, Torres TP, Byndloss AJ, Faber F, Gao Y, et al. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science. 2017;357:570–575. doi:10.1126/science.aam9949.
   Google Scholar
• Makki K, Deehan EC, Walter J, Bäckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23:705–715. doi:10.1016/j.chom.2018.05.012.
   Google Scholar
• Zhong H, Ren H, Lu Y, Fang C, Hou G, Yang Z, Chen B, Yang F, Zhao Y, Shi Z, et al. Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics. EBioMedicine. 2019;47:373–383. doi:10.1016/j.ebiom.2019.08.048.
   Google Scholar
• Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25:1096–1103. doi:10.1038/s41591-019-0495-2.
   Google Scholar
• Brahe LK, Le Chatelier E, Prifti E, Pons N, Kennedy S, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes. 2015;5:e159. doi:10.1038/nutd.2015.9.
   Google Scholar
• Hug H, Mohajeri MH, La Fata G. Toll-like receptors: regulators of the immune response in the human Gut. Nutrients. 2018;10:203. doi:10.3390/nu10020203.
   Google Scholar
• Yang J, Yan H. TLR5: beyond the recognition of flagellin. Cell Mol Immunol. 2017;14:1017–1019. doi:10.1038/cmi.2017.122.
   Google Scholar
• Aw W, Fukuda S. Understanding the role of the gut ecosystem in diabetes mellitus. Journal Diabetes Investig. 2018;9:5–12. doi:10.1111/jdi.12673.
   Google Scholar
• Saad MJA, Santos A, Prada PO. Linking Gut microbiota and inflammation to obesity and insulin resistance. Physiol. 2016;31:283–293. doi:10.1152/physiol.00041.2015.
   Google Scholar
• Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes. 2007;56:1761–1772. doi:10.2337/db06-1491.
   Google Scholar
• Tran HQ, Ley RE, Gewirtz AT, Chassaing B. Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases. Nat Commun. 2019;10:5650. doi:10.1038/s41467-019-13538-y.
   Google Scholar
• Zugasti O, Tavignot R, Royet J. Gut bacteria-derived peptidoglycan induces a metabolic syndrome-like phenotype via NF-κB-dependent insulin/PI3K signaling reduction in Drosophila renal system. Sci Rep. 2020;10:14097. doi:10.1038/s41598-020-70455-7.
   Google Scholar
• Platnich JM, Muruve DA. NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways. Arch Biochem and Biophys. 2019;670:4–14. doi:10.1016/j.abb.2019.02.008.
   Google Scholar
• Ðanić M, Stanimirov B, Pavlović N, Goločorbin-Kon S, Al-Salami H, Stankov K, Mikov M. Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome. Front Pharmacol. 2018;9:1382. doi:10.3389/fphar.2018.01382.
   Google Scholar
• Kim H, Fang S. Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis. Laboratory Animal Research. 2018;34(4):140–146. doi:10.5625/lar.2018.34.4.140.
   Google Scholar
• Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851–861. doi:10.1038/s41385-019-0162-4.
   Google Scholar
• Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JYL. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. 2018;68:1574–1588. doi:10.1002/hep.29857.
   Google Scholar
• Rodríguez-Morató J, Matthan NR. Nutrition and gastrointestinal microbiota, microbial-derived secondary bile acids, and cardiovascular disease. Curr Atheroscler Rep. 2020;22:47. doi:10.1007/s11883-020-00863-7.
   Google Scholar
• Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57:1–24. doi:10.1007/s00394-017-1445-8.
   Google Scholar
• Murakami M, Iwamoto J, Honda A, Tsuji T, Tamamushi M, Ueda H, Monma T, Konishi N, Yara S, Hirayama T, et al. Detection of Gut dysbiosis due to reduced clostridium subcluster xiva using the fecal or serum bile acid profile. Inflamm Bowel Dis. 2018;24:1035–1044. doi:10.1093/ibd/izy022.
   Google Scholar
• Hylemon PB, Harris SC, Ridlon JM. Metabolism of hydrogen gases and bile acids in the gut microbiome. FEBS Lett. 2018;592:2070–2082. doi:10.1002/1873-3468.13064.
   Google Scholar
• Smith NW, Shorten PR, Altermann EH, Roy NC, McNabb WC. Hydrogen cross-feeders of the human gastrointestinal tract. Gut Microbes. 2019;10(3):270–288. doi:10.1080/19490976.2018.1546522.
   Google Scholar
• Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Review of Gastroenterology & Hepatology. 2019;13(1):3–15. doi:10.1080/17474124.2019.1543023.
   Google Scholar
• van de Pol JAA, van Best N, Mbakwa CA, Thijs C, Savelkoul PH, Arts ICW, Hornef MW, Mommers M, Penders J. Gut colonization by methanogenic archaea is associated with organic dairy consumption in children. Front Microbiol. 2017:8. doi:10.3389/fmicb.2017.00355.
   Google Scholar
• Crovesy L, Masterson D, Rosado EL. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020;74(9):1251–1262. doi:10.1038/s41430-020-0607-6.
   Google Scholar
• Tomasova L, Konopelski P, Ufnal UM. Gut bacteria and hydrogen sulfide: the new old players in circulatory system homeostasis. Molecules. 2016;21(11):1558. doi:10.3390/molecules21111558.
   Google Scholar
• Bag S, Ghosh TS, Das B. Complete Genome Sequence of Collinsella aerofaciens Isolated from the Gut of a Healthy Indian Subject. Genome Announc. 2017;5:e01361–17. doi:10.1128/genomeA.01361-17.
   Google Scholar
• Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A. Hydrogen sulfide in the regulation of insulin secretion and insulin sensitivity: implications for the pathogenesis and treatment of diabetes mellitus. Biochem Pharmacol. 2018;149:60–76. doi:10.1016/j.bcp.2018.01.004.
   Google Scholar
• Gomez JAL, Mukhopadhya I, Duncan SH, Louis P, Shaw S, Collie-Duguid E, Crost E, Juge N, Flint HJ. Formate cross-feeding and cooperative metabolic interactions revealed by transcriptomics in co-cultures of acetogenic and amylolytic human colonic bacteria. Environ Microbiol. 2019;21(1):259–271. doi:10.1111/1462-2920.14454.
   Google Scholar
• Moreno-Navarrete JM, Serino M, Blasco-Baque V, Azalbert V, Barton RH, Cardellini M, Latorre J, Ortega F, Sabater-Masdeu M, Burcelin R, et al. Gut microbiota interacts with markers of adipose tissue browning, insulin action and plasma acetate in morbid obesity. Mol Nutr Food Res. 2018;62(3):1700721. doi:10.1002/mnfr.201700721.
   Google Scholar
• Vazquez‐Moreno M, Perez-Herrera A, Locia‐Morales D, Dizzel S, Meyre D, Stearns JC, Cruz M. Association of gut microbiome with fasting triglycerides, fasting insulin and obesity status in Mexican children. Pediatr Obes. 2020:e12748. doi:10.1111/ijpo.12748.
   Google Scholar
• Rousseau M, Guénard F, Garneau V, Allam-Ndoul B, Lemieux S, Pérusse L, Vohl M-C. Associations Between Dietary Protein Sources, Plasma BCAA and Short-Chain Acylcarnitine Levels in Adults. Nutrients. 2019;11(1):173. doi:10.3390/nu11010173.
   Google Scholar
• Chen T, Ni Y, Ma X, Bao Y, Liu J, Huang F, Hu C, Xie G, Zhao A, Jia W, et al. Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations. Sci Rep. 2016;6(1):20594. doi:10.1038/srep20594.
   Google Scholar
• Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, Forslund K, Hildebrand F, Prifti E, Falony G, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376–381. doi:10.1038/nature18646.
   Google Scholar
• Lischka J, Schanzer A, Hojreh A, Ssalamah AB, Item CB, Gier C, NK DW, TF M, Jakober I, Greber‐Platzer S, et al. A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity. Pediatr Obes. 2020;e12739. doi:10.1111/ijpo.12739.
   Google Scholar
• Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, Shi J, Zhao S, Liu W, Wang X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–868. doi:10.1038/nm.4358.
   Google Scholar
• Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. P-Cresyl Sulfate Toxins (Basel). 2017;9:52. doi:10.3390/toxins9020052.
   Google Scholar
• Saito Y, Sato T, Nomoto K, Tsuji H. Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. FEMS Microbiol Ecol. 2018;94(9):fiy125. doi:10.5625/lar.2018.34.4.140.
   Google Scholar
• Zhang X, Ojanen X, Zhuang H, Wu N, Cheng S, Wiklund WP. Branched-chain and aromatic amino acids are associated with insulin resistance during pubertal development in girls. J Adolesc Health. 2019;65(3):337–343. doi:10.1016/j.jadohealth.2019.01.030.
   Google Scholar
• Nicolucci AC, Hume MP, Martínez I, Mayengbam S, Walter J, Reimer RA. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology. 2017;153(3):711–722. doi:10.1053/j.gastro.2017.05.055.
   Google Scholar
• Joseph N, Vasodavan K, Saipudin NA, Yusof BNM, Kumar S, Nordin SA. Gut microbiota and short-chain fatty acids (SCFAs) profiles of normal and overweight school children in Selangor after probiotics administration. J Func Foods. 2019;57:103–111. doi:10.1016/j.jff.2019.03.042.
   Google Scholar
• Wang C, Nagata S, Asahara T, Yuki N, Matsuda K, Tsuji H, Takahashi T, Nomoto K, Yamashiro Y. Intestinal microbiota profiles of healthy pre-school and school-age children and effects of probiotic supplementation. Ann Nutr Metab. 2015;67(4):257–266. doi:10.1159/000441066.
   Google Scholar
• Golloso-Gubat MJ, Ducarmon QR, Tan RCA, Zwittink RD, Kuijper EJ, Nacis JS, Santos NLC. Gut microbiota and dietary intake of normal-weight and overweight filipino children. Microorganisms. 2020;8(7):1015. doi:10.3390/microorganisms8071015.
   Google Scholar